dividends
NYSE · IBD
Inspire Corporate Bond Impact ESG ETF
Financial Services · Asset Management - Bonds
$23.35
Up+$0.06 (+0.26%)
Updated Sep 18, 2026, 3:09 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 450.75M
- P/E ratio
- —
- Dividend yield
- 4.31%
- 52-week range
- $22.94 – $24.78
- Volume
- 35.52K
- Avg. volume
- 60.58K
Price performance
IBD price history
1M range · 20 trading sessions · Daily adjusted prices
IBD closed at $23.35 after 20 trading sessions, down 1.30% for the selected period.
- Last close
- $23.35
- Period change
- -1.30%
- Period low
- $23.29
- Period high
- $23.69
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $23.35 | $23.40 | $23.31 | $23.352 | 35.52K |
| Sep 16, 2026 | $23.33 | $23.6428 | $23.2601 | $23.29 | 72.35K |
| Sep 15, 2026 | $23.36 | $23.38 | $23.215 | $23.38 | 74.45K |
| Sep 14, 2026 | $23.305 | $23.37 | $23.28 | $23.37 | 54.84K |
| Sep 11, 2026 | $23.35 | $23.44 | $23.155 | $23.35 | 47.44K |
| Sep 10, 2026 | $23.42 | $23.6309 | $23.165 | $23.33 | 40.27K |
| Sep 9, 2026 | $23.55 | $23.60 | $23.4145 | $23.52 | 82.25K |
| Sep 8, 2026 | $23.54 | $23.56 | $23.45 | $23.45 | 159.33K |
| Sep 4, 2026 | $23.54 | $23.54 | $23.4552 | $23.505 | 50.78K |
| Sep 3, 2026 | $23.52 | $23.53 | $23.47 | $23.53 | 126.47K |
| Sep 2, 2026 | $23.48 | $23.4999 | $23.4443 | $23.48 | 76.23K |
| Sep 1, 2026 | $23.50 | $23.5187 | $23.40 | $23.51 | 68.39K |
| Aug 31, 2026 | $23.67 | $23.67 | $23.46 | $23.53 | 126.21K |
| Aug 28, 2026 | $23.69 | $23.69 | $23.51 | $23.55 | 85.61K |
| Aug 27, 2026 | $23.63 | $23.70 | $23.5397 | $23.62 | 70.27K |
| Aug 26, 2026 | $23.69 | $23.69 | $23.585 | $23.6384 | 76.91K |
| Aug 25, 2026 | $23.59 | $23.72 | $23.59 | $23.69 | 76.13K |
| Aug 24, 2026 | $23.58 | $23.6893 | $23.58 | $23.64 | 42.42K |
| Aug 21, 2026 | $23.67 | $23.71 | $23.5952 | $23.64 | 87.51K |
| Aug 20, 2026 | $23.65 | $23.6966 | $23.63 | $23.66 | 56.9K |
Latest IBD news
The latest Smart Investors Daily articles mentioning IBD.
Stock researchResearch & News · SEC Filings
Loading stock research…